Quantity | = | Concentration | x | Volume | x | Molecular Weight |
---|---|---|---|---|---|---|
= | x | x |
1) Click the Molarity Calculation Cart® button.
2) Specify the Concentration and Volume of your desired Molarity.
3) Click Calculate.
4) Your desired Quantity will be calculated and will be put under Quantity: (only for mg)
5) Click Add to Cart and then Proceed to checkout to complete the order. You will receive the quantity as you ordered as solvent-free form.
Alert: If you want to make a solution with a solvent (such DMSO), please add instructions in the notes section (such as 10 nM/1 mL in DMSO) and we will pack and deliver the product as a solution (such as 10 nM solution in 1 mL DMSO). If the product cannot be dissolved in DMSO or you would like to specify your own preferred solvent, please add detailed instructions in the notes section. All solutions must be shipped with an ice bag, costing an additional fee of $20 for S&H.
AOB4882
CAS No: 500363-63-3
Chemical Name: NSC-117079; 1-Amino-9,10-dioxo-4-(3-sulfamoylanilino)anthracene-2-sulfonic acid
AOBIOUS launched this product in 2016
CITATIONS - Publications That Use AOBIOUS Product
Warning: Last items in stock!
Availability date:
Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
---|---|---|---|
1 | 100 | $12.15 | Total: $1,215.00 |
1 | 50 | $14.04 | Total: $702.00 |
1 | 25 | $16.47 | Total: $411.75 |
1 | 10 | $19.44 | Total: $194.40 |
1 | 5 | $22.95 | Total: $114.75 |
Molecular Formula | C20H15N3O7S2 |
Molecular Weight | 473.48 |
CAS Numbers | 500363-63-3 |
Storage Condition | 0°C (short term), -20°C (long term), desiccated |
Solubility | DMSO |
Purity | 98% by HPLC |
Synonym | NSC-117079; NSC 117079; NSC117079 |
IUPAC/Chemical Name | 1-Amino-9,10-dioxo-4-(3-sulfamoylanilino)anthracene-2-sulfonic acid |
InChl Key | LHSBZAWDPSTOEY-UHFFFAOYSA-N |
InChl Code | InChI=1S/C20H15N3O7S2/c21-18-15(32(28,29)30)9-14(23-10-4-3-5-11(8-10)31(22,26)27)16-17(18)20(25)13-7-2-1-6-12(13)19(16)24/h1-9,23H,21H2,(H2,22,26,27)(H,28,29,30) |
SMILES Code | O=S(C(C(N)=C1C2=O)=CC(NC3=CC=CC(S(=O)(N)=O)=C3)=C1C(C4=C2C=CC=C4)=O)(O)=O |
References | 1) Hwang SM, Feigenson M, Begun DL, Shull LC, Culley KL, Otero M, Goldring MB, Ta LE, Kakar S, Bradley EW, Westendorf JJ. Phlpp inhibitors block pain and cartilage degradation associated with osteoarthritis. J Orthop Res. 2018 May;36(5):1487-1497. doi: 10.1002/jor.23781. Epub 2017 Nov 28. PMID: 29068480; PMCID: PMC5985222. 2) Hwang SM, Feigenson M, Begun DL, Shull LC, Culley KL, Otero M, Goldring MB, Ta LE, Kakar S, Bradley EW, Westendorf JJ. Phlpp inhibitors block pain and cartilage degradation associated with osteoarthritis. J Orthop Res. 2018 May;36(5):1487-1497. doi: 10.1002/jor.23781. Epub 2017 Nov 28. PMID: 29068480; PMCID: PMC5985222. |
Novel pan-PHLPP inhibitors (selective for PHLPP1 and PHLPP2)